欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号SE/H/0304/001
药品名称Avodart
活性成分
    • Dutasteride 0.5 mg
剂型Capsule, soft
上市许可持有人GlaxoSmithKline (Ireland) Limited
参考成员国 - 产品名称Sweden (SE)
互认成员国 - 产品名称
    • Germany (DE)
    • Belgium (BE)
    • Luxembourg (LU)
    • Ireland (IE)
    • Austria (AT)
      Avodart 0,5 mg Weichkapseln
    • France (FR)
    • Spain (ES)
    • Italy (IT)
    • Greece (GR)
    • Finland (FI)
    • Poland (PL)
    • Latvia (LV)
      Avodart 0,5 mg capsules, soft
    • Lithuania (LT)
      Avodart 0,5 mg minkštosios kapsulės
    • Hungary (HU)
      AVODART 0,5 mg lágy kapszula
    • Cyprus (CY)
      Avodart 0.5mg soft gel caps 24M0110
    • Czechia (CZ)
    • Slovakia (SK)
    • Slovenia (SI)
    • Malta (MT)
      Avodart 0,5mg capsules, soft
    • Romania (RO)
      AVODART 0,5 mg, capsule moi
    • Portugal (PT)
    • Estonia (EE)
    • Netherlands (NL)
许可日期2002/12/03
最近更新日期2024/09/17
药物ATC编码
    • G04CB02 dutasteride
申请类型
  • TypeLevel1:New Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Full Dossier Article 4.8 Di 65/65
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase